Sermorelin, also known as GRF 1-29, is a synthetic 29-amino-acid peptide analogue of growth hormone-releasing hormone, or GHRH. It is studied for its interaction with the GHRH receptor and its role in stimulating the body’s natural growth-hormone signaling pathway.
In research settings, sermorelin has been investigated in relation to growth-hormone secretion, IGF-1 signaling, endocrine function, body-composition markers, immune-function markers, aging-related hormone changes, recovery pathways, and diagnostic testing for growth-hormone deficiency.
Potential Human Benefits Being Investigated
- Growth-hormone signaling research
- IGF-1 pathway research
- Pituitary-function research
- Endocrine-health marker research
- Body-composition biomarker research
- Lean-mass and muscle-maintenance pathways
- Fat-metabolism and lipolysis-related research
- Recovery and tissue-repair pathway research
- Exercise-recovery research
- Sleep-quality and slow-wave sleep research
- Energy and vitality marker research
- Bone-density and connective-tissue research
Reviews
There are no reviews yet.